Long-term STDs can increase your risk for urogenital cancers
The identification of the association of the STDs with the possible risks for cancers of the urogenital systems is central to elaborating a proper approach to prevention. Many studies suggest that viral and bacterial STDs may increase the risk of different types of genitourinary cancers through eliciting inflammatory responses and favoring neoplastic transformation.
Although the exact mechanisms of such changes are still under investigation, the dependence of cervical cancer on HPV infection is clearly pronounced, as it depresses several types of cells that can restrain tumor development.
30 September 2024
5 min read
1757
The Role of Chronic STDs in Cancer Development
Chronic irritation or inflammation caused by chronic STDs frequently provides a premalignant state that is conducive to carcinogenesis. Many of the STDs are notoriously silent, a challenge to diagnose, and may smolder for indefinite periods with no apparent signs. Testing is the most surefire method of detection and diagnosis of such infections.
Understanding Chronic STDs
Sexually transmitted disease, or STD, is an infection which one gets through certain sexual behaviors.
If left untreated, some of the STDs become chronic, whereas others, though incurable, can successfully be maintained with medication. The origins of STDs may either be viral, or bacterial and parasitic in nature. Classic examples of persistent viral STDs include herpes and the human papillomavirus (HPV). In the long term, studies indicate that chronic sexually transmitted diseases enhance one's risk for bladder, urethral, cervical, and ovarian cancer.
Overview of Bladder and Urethra Cancer
Urethral cancer results from the malignant transformation of cells lining the lumen of the urethra. These cells may then proliferate out of control and eventually migrate to other tissues and parts of the body. Although urethral cancer is infrequent, it is more common among men, hence posing diagnosis problematic. Bladder cancer, affecting the bladder, is the fourth most common type of cancer in men.
Gonorrheal and other viral infections are associated with an increased risk for these cancers, while human papillomavirus type 16 already contributes in a major way to bladder cancer.
Cervical and Ovarian Cancer: Important Facts
Ovarian and cervical cancers are the severe health concerns among females all over the world. Ovarian cancer includes the carcinomatous transformation of ovarian cells. In cervical cancer, a majority of the lesions present in the cervix are low malignant and it is closely associated with high-risk HPV types. Moreover, cervical cancers have been found to arise due to infections like HPV(16 and 18), and Chlamydia, and ovarian cancers can rise due to Chlamydia, Gonorrhea, and M.genitalium infections.
Understanding Signs and Symptoms of Urogenital Cancers
Symptom recognition is very crucial for the timely diagnosis of the cancers of the urogenital tract. While symptoms vary with the cancer, some common signs and symptoms include blood in the urine, frequent urination, painful urination, abdominal bloating, changes in bowel habits, and bleeding that is intermittent.
Effective Treatments against Urogenital Cancers
Treatment modalities include surgery, chemotherapy, immunotherapy, targeted therapy, radiation, and symptom-based palliative care. The appropriate treatment option will be chosen depending on the type of cancer and the extent/stage of disease, in addition to the patient's general health.
Risk Reduction Strategies for Urogenital Cancers
This also constitutes an important modus operandi of lowering the risk of urogenital cancers: adoption of a healthy lifestyle and avoidance of known risk factors. While some of the risk factors, such as genetics and family history, cannot be changed, others can be modified: smoking, chronic STDs, and urinary tract infections. Early detection and timely treatment of the latter—STDs—lowers the risk of these cancers.
In other words, the knowledge of the association of STDs with urogenital cancers is accompanied by the possibility of effective prevention strategies, resulting in radically lowered incidence rates for these types of cancer.
Prevention and Early Detection of STDs
The prevention of STDs forms an important part of reducing risk from urogenital cancers. The best means to prevent chronic STDs are safe sex, regular screening, and early treatment. Most of the STDs, including high-risk ones like HPV and herpes, can be effectively managed, provided they are detected early.
Longer 'medical check-ups and screening' can also facilitate the early diagnosis of cancers. For instance, Pap tests may enable the detection of cervical cancer in women at an earlier stage of the disease, which may serve to increase the likelihood of successful treatment. Urine tests and cystoscopies may enable the early detection of bladder cancers. It is entirely advisable that a person who is at a high risk of urogenital cancers consult their health professional on measures of prevention and screening that best suit them.
Lifestyle Changes
It is also advisable to maintain a proper lifestyle in order to reduce the risk of cancers in the urogenital system. Certain lifestyle modifications, such as including exercise, following a proper diet, quitting smoking, and avoiding alcohol can surely reduce the chances of cancer.
HPV Vaccination
Vaccination against HPV is a potent way to prevent cancers of several types, including cervical and certain forms of bladder cancer. Vaccination against HPV is advised for both boys and girls when they reach a young, tender age—well before they become sexually active.
While the chronic sexually transmitted diseases clearly relate to a certain increased risk for cancers of the urogenital tract, it does not necessarily mean cancer will occur. The risk can be diminished by regular testing, early treatment of the STDs, prevention, and healthy lifestyle choices. The healthy proactive approach in sexual health and recommended guidelines on cancer screening will definitely reduce the chances of developing urogenital cancers to a great extent. And, in fact, it is possible to win the fight against cancers with all these measures.
References
"HIV Basics" - Centers for Disease Control and Prevention (CDC) - Link
"HIV/AIDS" - World Health Organization (WHO) - Link
"HIV Treatment: The Basics" - U.S. Department of Health & Human Services - Link
"Preventing New HIV Infections" - Mayo Clinic - Link
"Post-Exposure Prophylaxis (PEP)" - HIVinfo - Link
"Pre-Exposure Prophylaxis (PrEP)" - Centers for Disease Control and Prevention (CDC) - Link
"Stages of HIV Infection" - U.S. Department of Health & Human Services - Link
For Men & Women
Results in Minutes
No Lab Needed
Private & Discreet
